Ocrelizumab Modulates Both B and T Cell Immune Capacities in Multiple Sclerosis
Qi Wu, Mikel Gurrea‐Rubio, Q. Wang, Deanna Dwyer, Elizabeth Anne Mills, Joshua W. Garton, Joshua S Mytych, Steven K. Lundy, Christopher D. Scharer, Jeremy M. Boss, Laura A. Cooney, Dean E. Draayer, Phillip L. Campbell, David A. Fox, Yang Mao‐Draayer
This study examines how ocrelizumab affects B and T cell populations in MS patients, revealing changes in B cell subsets and T cell dynamics, along with altered signaling pathways.
bioRxiv · Mar 26, 2026 · PreprintImmunology